RJS College of Pharmacy Kokamthan
The unit of micro-emulsions mixes with at least one hydrophilic, one hydrophobic, and one ampiphilic half that are optically and macroscopically isotropic. These are clear, unit stable compared to other emulsion forms, and typically used in conjunction with a co-surfactant. Their diameter falls between 10 to 140 µm. These days, micro-emulsion formulations are widely used to deliver hydrophilic medications; however, because lipophilic medications act as drug carriers, they require a number of additional fantastic properties, such as long half-lives, improved bioavailability, preparation comfort, ultra-low surface tension, and large surface area. Because of their extended shelf life, improved drug solubilization, and ease of preparation and administration, microemulsions are a popular choice for innovative drug delivery devices. Oil, water, and amphiphile solutions that are thermodynamically stable are called microemulsions. They have become new. vehicles for drug delivery that enable parenteral, topical, transdermal, ocular, and percutaneous drug administration with controlled or sustained release. It is easy to distinguish microemulsions from regular emulsions due to their low viscosity, transparency, and—most importantly—thermodynamic stability.
The definition of a Microemulsion is a transparent, stable, isotropic liquid mixture of water, oil, and surfactant, or a combination of these substances. In pharmaceutical research, creating a new drug delivery system with the goal of increasing efficacy is a continuous process. Since then, numerous medication delivery system kinds have been created. By dispersing oil, aqueous surfactant solution, and micro emulsion using polyethylene glycol as a co-surfactant, they created the first micro emulsion, which produced a stable and transparent formulation. Over time, there has been a lot of interest in microemulsions as possible drug delivery vehicles. Several characteristics of micro emulsion-based formulations include improved drug solubilization, strong thermodynamic stability, and simplicity of production. Drug delivery can be accomplished in a number of ways with microemulsions, which are flexible systems. Numerous studies have been conducted on these systems for topical delivery. Microemulsions can improve systemic or local drug delivery as a topical carrier by using a new method. The tiny emulsion Because it can improve drug solubilization, it is an excellent option for oral delivery of weakly water-soluble medications. As a drug’s thermodynamic activity in the vehicle increases, so does its absorption rate. Emulsions are essential to a lot of the cosmetics we use today. Over the years, a lot of literature has been produced regarding the development and stability of these water-dispersed (o/w) or water-dispersed oil systems (without). Nonetheless, the cosmetic formulator continues to strive to comprehend and produce the most aesthetically pleasing and useful Micellar emulsion, also known as Microemulsion, is a dynamic system in which the interface fluctuates continually and spontaneously. They can be classified as bi-continuous microemulsions, water in oil (W/O), and oil in water (O/W). Maintaining the interfacial layer’s flexibility in W/O forms lowers interfacial tension. Water droplets are distributed in the continuous oil phase to produce microemulsions, whereas oil droplets are distributed in the continuous aqueous phase to form O/W micro emulsion identified four types of equilibrium micro emulsion phases, which are referred to as Winsor phases. These phases are as follows:
A. Winsor I: The lower o/w micro emulsion phase and the upper oil layer are in balance in this two-phase system.
B. Winsor II: The two-phase system’s upper microemulsions (w/o) and lower excess water equilibrium are in balance. The middle bicontinuous phase of o/w, known as W/O, is in equilibrium with the upper oil phase and the lower water phase.
C Winsor III (triphasic system). The single-phase system
D. Winsor IV: Creates a uniform blend of water, oil, and surfactant.
Composition:
The micro emulsion system is composed of the following primary parts:
1) Oil stage
2) Primary surfactant (surfactant)
3) Co-surfactant, also known as secondary surfactant.
4) Phase of Co-solvent:
1) Oil:
The oil phase is the second most significant vehicle after water because of its ability to improve absorption through the body’s lipid barrier and solubilize lipophilic medication molecules.
Example: Lauric, Myristic, and Capric acids are saturated fatty acids. Oleic, linoleic, and linolenic acids are unsaturated fatty acids. Lauric, myristic, and oleic acid esters can be either ethyl or methylated to form fatty acid esters.
2. Surfactants:
To help all of the components disperse, the surfactant used in the microemulsions preparation process needs to be able to keep the interfacial tension as low as feasible. These surfactants include: Cationic Zwitterionic, Anionic, and Nonionic. The following are examples: Polyoxyl 35 hydrogenated castor oil (Cremophor EL) and Polyoxyl 40 castor oil (Cremophor RHCo surfactants).
3. Co-surfactants:
High concentrations of single-chain surfactants were found to be necessary to reduce the o/w interfacial tension to a point where a micro emulsion can form spontaneously. One example would be short-chain alcohols, such ethanol to butanol. 2) Glycols with short chains, such propylene glycol.
4. Co-solvents:
These organic solvents, which include ethanol, propylene glycol (PG), and polyethylene glycol (PEG), aid in the dissolution of generally high concentration.
Advantages:
The drawbacks of micro emulsion:
1) Need a lot of co-surfactant and surfactant to stabilize droplets.
2) Limited solubility for compounds with high melting points.
3) Environmental factors like pH and temperature affect stability.
Different Microemulsion Delivery Methods:
Compared to the conventional oral formulation for oral administration, micro emulsion formulations have a number of benefits, such as enhanced absorption, enhanced clinical efficacy, and decreased drug toxicity. With mild agitation, a self-emulsifying drug delivery system called “SEDDS”—a mixture of oil and a drug-containing surfactant—forms a micro emulsion of oil in water in aqueous media, which served as the model for this kind of delivery. One of the many variables influencing SEDDS absorption is the existence of bile salts. The quantity of bile salts integrated into the emulsion droplets’ surfactant layers ultimately results in medication malabsorption.
2) Skin delivery:
This is the earliest method of administration to employ the micro emulsion technology. The dosage form’s objective is to maximize flux via the skin when applied transdermally into the bloodstream. Microemulsions have been used to successfully administer lidocaine, apomorphine, estradiol, and ketoprofen transdermally. Studies on human skin irritation were conducted using lecithin liposomes and a lecithin micro emulsion gel. For a number of reasons, including avoiding first-pass hepatic drug metabolism and its related harmful consequences, dermal drug delivery may be superior to alternative techniques. The medicine is delivered directly to the organ that is impacted, which is the other benefit. Vaccines have historically been given by needle injection. Recently, there has been a lot of interest in topical vaccination using protein- or DNA-based vaccines through intact skin.
3) Ocular Delivery:
One of the most promising methods for employing the ocular route is the micro emulsion method. Ocular applications are better suited for micro emulsion formulations due to their transparency. Eye drops are the most popular method of delivery via the body, despite their poor bioavailability. identified a novel micro emulsion delivery system for topical dexametasone ocular administration. Microemulsions are potential delivery technologies for ocular medications due to their special qualities and many benefits. ME may enhance the drug’s water solubility and enhance its absorption in the eye. The micro emulsion system demonstrated good stability and appropriate physicochemical behavior during a three-month period.
4) Ocular Drug delivery:
In traditional ocular dose forms, water-soluble medications are administered as aqueous solutions, whereas water-insoluble medications are prepared as ointments or suspensions. Among these systems’ major issues are low corneal bioavailability and inefficiency in the posterior region of ocular tissue.
5) Nasal delivery:
In order to improve drug absorption through the nasal mucosa, microemulsions have recently been investigated as a delivery method. Additionally, the muco-adhesive polymer aids in extending the mucosa’s residence period. Lianly et al. looked into how diazepam affected status epilepticus emergency care. They discovered that diazepam was rather quickly absorbed through the nose at a dose of 2 mg kg-1, with the maximal drug plasma concentration occurring in two to three minutes.
6) Parenteral Administration:
Giving medications by parenteral means, especially through an intravenous solubility is one of the main issues facing the industry because so little medication is actually transported to the intended location. Because fine-particle microemulsions are eliminated more slowly than coarse-particle emulsions and so have a longer residence time in the body, micro emulsion formulations offer clear advantages over macro emulsion systems when given parenterally. Microemulsions that are O/W or W/O can be administered parenterally. The physiological effects of pharmaceutical peptide and protein medications are highly selective and powerful, and they are challenging to take orally. Most protein medicines are only available as parenteral formulations because of their poor bioavailability.
Microemulsion preparation method:
There are two primary techniques described for creating the microemulsions.
1) Phase titration method
2) Phase Inversion method
Phase Inversion Method
In the phase inversion method phase inversion of microemulsions occurs by the addition of excess amount of the dispersed phase. During phase inversion quick physical changes occur including changes in particle size that can affect drug release both in vivo and in vitro. For non-ionic surfactants, this can be completed by changing the temperature, forcing a transition from oil in water microemulsion at low temperatures to water in oil microemulsion at higher temperatures (transitional phase inversion). During cooling, the system crosses a point of zero spontaneous curvature and minimal surface tension, promoting the formation of finely dispersed oil droplets. This method is also known as phase inversion temperature (PIT) method. Other than temperature, other parameters such as pH value or salt concentration may be considered more effectively instead of the temperature alone. Additionally, a transition in the spontaneous radius of curvature can be obtained by changing the water volume fraction. By successively adding water into oil, initially water droplets are formed in a continuous oil phase. By increasing the water volume fraction changes the spontaneous curvature of the surfactant from initially stabilizing a w/o microemulsion to an o/w microemulsion at the inversion point.
Phase Titration Method
Microemulsions are formulated by the spontaneous emulsification method (phase titration method) and can be shown with the help of phase diagrams. A mixture of fatty acid and oil is added to a caustic solution to prepare a microemulsion, then after it is titrated with a cosurfactant, an alcohol, until the system turned clear. Microemulsions are formed along with various association structures (including emulsion, micelles, lamellar, hexagonal, cubic, and various gels and oily dispersion) depending on the chemical composition and concentration of each component. It is found that as the chain length of the surfactant increased, microemulsions with significant transmittances by visible spectrum can be formed with oils of longer chain lengths. It is also found that different alcohols affect the formation of microemulsions in different ways. The best results, in terms of the greatest percent transmittance coupled with the widest range of oil (dispersed in water) concentration, are obtained from short or branched alcohols.
Formula:
|
Sr no. |
ingredient |
quantity |
Uses |
|
1 |
Azithromycin |
500mg |
Treat bacterial infection |
|
2 |
Olive oil |
15ml |
Penetration enhacer |
|
3 |
Tween 80 |
7ml |
Emulsifier |
|
4 |
PEG400 |
5ml |
Humectant |
|
5 |
Distilled water |
q.s |
vehicle |
Evaluation of Microemulsion:
Microemulsions are usually somewhat opalescent and light yellow in color.
By precisely measuring 1 milliliter of prepared micro emulsion that has been dispersed in 10 milliliters of pure water. A digital pH meter was used to measure the pH. The pH of 5.7 of the preparation has been determined.
The preparation’s viscosity (1.613 cp) has been established. The ability to distinguish between o/w systems (10 to 1000 uS/cm) and w/o systems (<10 uS/cm) is facilitated by conductivity. A conductivity of 395 uS/cm has been established for the preparation.
The formulation’s determined amount of active pharmaceutical ingredient (API) using UV visible spectrophotometer. It was determined that the drug content was 98.80%.
The formulation’s stability and surface charge are indicated by the zeta potential. The general range of zeta potentials is +0 to +10 mV: Low stability (particles inclined to agglomerate) +Stability is moderate between 10 and +30mV High stability (excellent electrostatic repulsion) at 30mV or above.30 mV has been identified as the zeta potential.
CONCLUSION:
Drug delivery devices that distribute multiple medications at once are called microemulsions. Microemulsions have been shown to protect labile drugs, regulate drug release, improve drug solubility, boost bioavailability, and decrease patient variability. They have also made it feasible to create formulations that work with the majority of delivery routes. Microemulsions role in offering innovative ways to address the issues of highly lipophilic drug compounds’ poor aqueous solubility and in delivering high, more reliable, and consistent bioavailability. In order to achieve regulated release with improved bioavailability and to target different parts of the body.
REFERENCE
Prerana Jamdhade*, Vaishnavi Dhage, Suvarna Sangale, Snehal Gondkar, Tanvir Pathan, Gursal Kanchan, A Review On: Microemulsion, Int. J. Sci. R. Tech., 2026, 3 (3), 261-268. https://doi.org/10.5281/zenodo.19015858
10.5281/zenodo.19015858